Author | Jason Valent, MD | OncLive

Author | Jason Valent, MD

Articles

Dr. Valent on Ongoing Research With Immunotherapy in Multiple Myeloma

February 06, 2019

Jason Valent, MD, an oncologist at Cleveland Clinic, discusses ongoing research with immunotherapy, specifically checkpoint inhibitors, in the treatment of patients with multiple myeloma.

Dr. Valent on Dose-Adjusted Carfilzomib in Myeloma

November 06, 2018

Jason Valent, MD, an oncologist at Cleveland Clinic, discusses the recent FDA approval of dose-adjusted carfilzomib in patients with myeloma.

Dr. Valent on MRD Negativity in Multiple Myeloma

October 11, 2018

Jason Valent, MD, oncologist, Cleveland Clinic, discusses the potential application of minimal residual disease (MRD) negativity in patients with multiple myeloma.

x